Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy | Zendy

Tamara Kovačević-Preradović | Zendy; M Zuber | Zendy; Christine H. Attenhofer Jost | Zendy; U. Widmer | Zendy; Burkhardt Seifert | Zendy; Gustav K. von Schulthess | Zendy; Andrea Fischer | Zendy; Rolf Jenni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy

Author(s) -

Tamara Kovačević-Preradović,

M Zuber,

Christine H. Attenhofer Jost,

U. Widmer,

Burkhardt Seifert,

Gustav K. von Schulthess,

Andrea Fischer,

Rolf Jenni

Publication year - 2008

Publication title -

european journal of echocardiography

Language(s) - English

Resource type - Journals

eISSN - 1525-2167

pISSN - 1532-2114

DOI - 10.1093/ejechocard/jen129

Subject(s) - medicine , enzyme replacement therapy , fabry disease , cardiology , interventricular septum , diastole , cardiomyopathy , left ventricular hypertrophy , creatinine , heart failure , disease , blood pressure , ventricle

Anderson-Fabry disease affects various organ systems due to glycosphingolipid accumulation. Enzyme replacement therapy (ERT) has been reported to decrease left ventricular wall thickening (LVWT) and to improve diastolic dysfunction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research